# METiS TechBio (7666.HK) is a tech-bio company focused on AI-powered nanodelivery innovation.

*biotech · news · 2026-05-14 · The Manila Times*

## Key points

- METiS TechBio is the world's first publicly listed AI-powered drug delivery company on HKEX.
- Its proprietary NanoForge platform includes the world’s only de novo lipid generation algorithm and language model.
- MTS-004 is China’s first AI-enabled formulation drug to complete a Phase III clinical trial.
- MTS-105 may become the world’s first in vivo mRNA-encoded TCE therapy for solid tumors.

**Companies:** BlackRock, UBS Asset Management, Deutsche Bank Securities, Jefferies, CITIC Securities, METiS TechBio
**Countries:** China, Hong Kong, South Korea, Japan, United States

[Read the full story on The Manila Times](https://www.manilatimes.net/2026/05/14/tmt-newswire/pr-newswire/metis-techbio-the-worlds-first-publicly-listed-ai-powered-drug-delivery-company-debuts-on-the-hong-kong-stock-exchange-the-spacex-of-pharmaceuticals-ushers-in-a-new-era-of-biopharmaceuticals/2343541)

---

Canonical: https://newsio.io/n/de80b7c2-31dc-4172-b6a9-a44ae16f814a/metis-techbio-7666-hk-is-a-tech-bio-company-focused-on-ai-powered-nanodelivery-i
Summarized by Newsio from The Manila Times. https://newsio.io/how-it-works